For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
A biopharmaceutical, also known as a biologic medical product, biological,or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They are isolated from living sourceshuman, animal, plant, fungal, or microbial.
The Biopharmaceuticals market revenue was 256353.15 Million USD in 2022, and will reach 433073.01 Million USD in 2028, with a CAGR of 9.13% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Biopharmaceuticals industry, and breaks down according to the type, application, and consumption area of Biopharmaceuticals. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Biopharmaceuticals in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Biopharmaceuticals market covered in Chapter 11:
Pfizer
Roche
Novartis
Sanofi-Aventis
Amgen
Eli Lilly
Merck
AbbVie
Novo Nordisk
Johnson & Johnson
In Chapter 3, on the basis of types, the Biopharmaceuticals market from 2018 to 2028 is primarily split into:
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
In Chapter 4, on the basis of applications, the Biopharmaceuticals market from 2018 to 2028 covers:
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028